CSIMarket
 


Amgen Inc   (AMGN)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare

Amgen Inc 's Leverage Ratio

AMGN's quarterly Leverage Ratio and Total Liabilities, Equity growth




AMGN Leverage Ratio (Mar 31 2021)
I. Quarter
(Dec 31 2020)
IV. Quarter
(Sep 30 2020)
III. Quarter
(Jun 30 2020)
II. Quarter
(Mar 31 2020)
I. Quarter
Y / Y Equity Change -1.59 % -2.73 % 0.29 % -1.25 % -12.44 %
Y / Y Total Liabilities Change 2.8 % 7.01 % 10 % 11.35 % -2.65 %
Leverage Ratio MRQ 5.7 5.69 4.88 5.07 5.46
Overall Ranking # # # # #
Seq. Equity Change -0.8 % -14.14 % 2.81 % 12.38 % -1.94 %
Seq. Total Liabilities Change -0.62 % 0.13 % -1.16 % 4.51 % 3.44 %



Leverage Ratio first quarter 2021 Comment
Despite repayements of liabilities of -0.62%, in I. Quarter ,Leverage Ratio detoriated to 5.7, a new company high.

Within Biotechnology & Drugs industry in the first quarter 2021, 183 other companies have achieved lower Leverage Ratio than Amgen Inc . While total ranking remained unchanged compare to previous quarter at no. .

Explain Leverage Ratio?
Who are AMGN Customers?
Leverage Ratio first quarter 2021 Company Ranking
Within: No.
Biotechnology & Drugs Industry # 184
Healthcare Sector # 739
Overall Market # 3149


Leverage Ratio Statistics
High Average Low
5.7 1.67 0.33
(Mar 31 2021)   (March 31, 2004)




Financial Statements
Amgen Inc 's Equity $ 9,334 Millions Visit AMGN's Balance sheet
Amgen Inc 's Total Liabilities $ 53,205 Millions Visit AMGN's Balance sheet
Source of AMGN's Sales Visit AMGN's Sales by Geography




Companies with similar Leverage Ratio in the quarter endingMar 31 2021, within Biotechnology & Drugs Industry Leverage RatioMar 31 2021 MRQ Total LiabilitiesMar 31 2021 MRQ Equity
Enzon Pharmaceuticals Inc   12.00 $ 82.393  Millions$ 6.865  Millions
Abbvie Inc   9.69 $ 133,023.000  Millions$ 13,733.000  Millions
Eloxx Pharmaceuticals Inc   6.41 $ 17.616  Millions$ 2.750  Millions
Axim Biotechnologies Inc   5.92 $ 9.640  Millions$ 1.629  Millions
Protalix Biotherapeutics inc   5.73 $ 83.111  Millions$ 14.504  Millions
Amgen Inc   5.70 $ 53,205.000  Millions$ 9,334.000  Millions
Aptevo Therapeutics Inc   5.55 $ 58.249  Millions$ 10.504  Millions
Pactiv Evergreen Inc   5.13 $ 5,267.000  Millions$ 1,026.000  Millions
Coherus Biosciences inc   4.36 $ 556.388  Millions$ 127.671  Millions
Pulse biosciences inc   2.95 $ 60.160  Millions$ 20.397  Millions
Cannabis Global Inc   2.70 $ 11.510  Millions$ 4.259  Millions
Aziyo Biologics Inc   2.50 $ 41.134  Millions$ 16.444  Millions
Avantor Inc   2.22 $ 6,219.700  Millions$ 2,806.100  Millions
Gilead Sciences Inc   2.15 $ 40,707.000  Millions$ 18,964.000  Millions
Cytomx Therapeutics Inc   1.97 $ 288.136  Millions$ 146.022  Millions
Acorda Therapeutics inc   1.83 $ 377.769  Millions$ 206.279  Millions
Reynolds Consumer Products Inc   1.82 $ 2,996.000  Millions$ 1,643.000  Millions
Iterum Therapeutics Plc  1.73 $ 54.660  Millions$ 31.517  Millions
Integrated Biopharma Inc  1.68 $ 16.382  Millions$ 9.749  Millions
Novavax inc   1.51 $ 1,569.239  Millions$ 1,039.127  Millions
Eyenovia Inc   1.38 $ 16.712  Millions$ 12.140  Millions
Surgalign Holdings Inc   1.30 $ 60.133  Millions$ 46.384  Millions
Oncotelic Therapeutics Inc   1.28 $ 14.036  Millions$ 10.961  Millions
Cure Pharmaceutical Holding Corp   1.26 $ 25.079  Millions$ 19.859  Millions
Biogen Inc   1.24 $ 13,172.500  Millions$ 10,663.200  Millions
Codiak Biosciences Inc   1.23 $ 84.622  Millions$ 68.716  Millions
Cv Sciences Inc   1.22 $ 14.596  Millions$ 11.964  Millions
Nanostring Technologies Inc   1.20 $ 284.166  Millions$ 236.392  Millions
Outlook Therapeutics Inc   1.18 $ 24.461  Millions$ 20.651  Millions
Navidea Biopharmaceuticals Inc   1.16 $ 5.799  Millions$ 5.009  Millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

CLAA's Profile

Stock Price

CLAA's Financials

Business Description

Fundamentals

Charts & Quotes

CLAA's News

Suppliers

CLAA's Competitors

Customers & Markets

Economic Indicators

CLAA's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071